lower
respiratori
tract
infect
respiratori
syncyti
viru
rsv
foremost
caus
infant
hospit
implic
last
pulmonari
impair
develop
asthma
neutrophil
infiltr
airway
pediatr
patient
rsvinduc
bronchiol
vast
number
approxim
infiltr
cell
neutrophil
howev
neutrophil
recruit
site
viral
respiratori
tract
infect
clear
review
discuss
benefici
patholog
contribut
neutrophil
immun
respons
rsv
infect
neutrophil
limit
viral
replic
spread
well
stimul
effect
antivir
adapt
immun
respons
howev
low
specif
neutrophil
antimicrobi
armament
allow
collater
tissu
damag
neutrophilinduc
injuri
airway
delic
period
infant
lung
develop
last
advers
consequ
pulmonari
architectur
might
promot
onset
asthma
suscept
subject
suggest
pharmacolog
modul
neutrophil
explor
viabl
futur
therapi
sever
rsvinduc
bronchiol
therebi
prevent
incept
subsequ
asthma
antivir
function
neutrophil
suggest
target
neutrophil
patient
rsvinduc
bronchiol
best
perform
umbrella
antivir
treatment
j
allergi
clin
immunol
respiratori
syncyti
viru
rsv
ubiquit
season
human
pathogen
infect
upper
respiratori
tract
caus
coldlik
symptom
healthi
adult
children
year
age
nearli
children
infect
rsv
least
lower
respiratori
tract
infect
lrti
rsvare
major
caus
morbid
mortal
among
infant
annual
rsvassoci
mortal
estim
quarter
million
death
per
year
occur
develop
countri
account
approxim
death
among
infant
younger
year
age
develop
world
infant
admit
hospit
rsvinduc
bronchiol
therefor
foremost
caus
infant
hospit
winter
season
sever
rsvinduc
bronchiol
infanc
link
impair
lung
function
adulthood
causal
implic
onset
recurr
wheez
asthma
massiv
pulmonari
neutrophil
infiltr
observ
pediatr
patient
rsvinduc
bronchiol
lower
airway
neutrophil
account
median
infiltr
cell
median
upper
airway
measur
bronchoalveolar
lavag
fluid
nasopharyng
aspir
respect
similarli
postmortem
histopatholog
analys
fatal
rsvrelat
lrti
case
reveal
extens
neutrophil
infiltr
airway
wall
lumen
well
alveoli
beg
question
neutrophil
recruit
en
mass
site
viral
respiratori
tract
infect
wide
varieti
inflammatori
stimuli
purpos
attract
neutrophil
lung
clear
invad
bacteria
apoptot
debri
foreign
substanc
could
neutrophil
also
function
protect
rsv
infect
neutrophil
abund
leukocyt
human
circul
classic
portray
unsophist
firstlin
foot
soldier
role
limit
engulf
subsequ
elimin
invad
extracellular
bacteria
fungi
view
lunginfiltr
neutrophil
seem
place
rsv
infect
promiscu
cytotox
neutrophil
antimicrobi
armament
might
even
potenti
virusinduc
lung
injuri
inde
degre
neutrophil
inflamm
correl
diseas
sever
patient
rsvinduc
bronchiol
moreov
common
singl
nucleotid
polymorph
upstream
gene
tent
associ
increas
product
potent
neutrophil
chemoattract
frequent
among
infant
sever
rsvinduc
bronchiol
particular
among
infant
lack
known
risk
factor
increas
level
airway
patient
bronchiol
link
increas
diseas
sever
measur
base
oxygen
satur
silverman
score
respiratori
rate
gene
relat
neutrophil
function
encod
elastas
overexpress
blood
patient
rsvinduc
bronchiol
express
level
posit
correl
diseas
sever
thu
neutrophil
thought
contribut
lung
injuri
patient
sever
rsvinduc
bronchiol
exact
role
pathogenesi
still
unclear
larg
bodi
epidemiolog
evid
includ
prospect
casecontrol
cohort
studi
implic
rsvinduc
bronchiol
infanc
incept
recurr
wheez
last
lung
function
impair
howev
associ
wheez
histori
rsvinduc
bronchiol
infanc
partial
subsid
age
clear
extent
rsvinduc
bronchiol
relat
increas
risk
asthma
school
age
beyond
nonetheless
nearli
half
children
sever
rsvinduc
bronchiol
present
asthma
year
age
estim
indic
earlylif
rsvinduc
bronchiol
respons
childhood
asthma
case
moreov
smoke
adult
rsvinduc
bronchiol
infanc
without
lrti
earli
life
increas
risk
persist
asthma
howev
associ
necessarili
impli
causat
sever
rsvinduc
bronchiol
could
occur
mainli
infant
preexist
suscept
asthma
develop
common
genet
andor
environment
factor
appear
underli
predisposit
diseas
recent
address
issu
causal
random
doubleblind
placebocontrol
clinic
trial
rsv
immunoprophylaxi
healthi
preterm
infant
demonstr
causal
relationship
rsvinduc
bronchiol
develop
recurr
wheez
although
wheez
earli
life
strong
risk
factor
asthma
earli
adulthood
asthma
trial
need
provid
conclus
evid
rsv
diseas
causal
relat
persist
asthma
neutrophil
play
import
role
asthma
exacerb
induc
mucu
hypersecret
airway
remodel
result
acut
revers
progress
irrevers
airway
obstruct
respect
although
neutrophil
thought
affect
lung
function
decreas
role
asthma
incept
viral
bronchiol
understudi
nonetheless
sever
infant
bronchiol
show
doserespons
relationship
risk
morbid
childhood
asthma
discuss
degre
neutrophil
inflamm
correl
sever
rsvinduc
bronchiol
therefor
sever
neutrophil
lung
inflamm
infanc
could
tenabl
predispos
children
subsequ
wheez
onset
asthma
inde
function
polymorph
frequent
among
infant
sever
rsvinduc
bronchiol
also
overrepres
infant
postbronchiol
wheez
compar
patient
bronchiol
wheez
afterward
neutrophil
inflammationinduc
collater
tissu
damag
airway
sensit
could
mediat
develop
asthma
suscept
transient
damag
develop
infant
lung
farreach
last
advers
consequ
pulmonari
anatomi
function
particularli
true
critic
process
alveolar
multipl
septat
disrupt
elastin
fiber
present
alveolar
duct
septal
wall
provid
elast
lung
transmit
cue
mechan
stress
stimul
alveolar
neutrophil
elastas
releas
neutrophil
recruit
lung
degrad
elastin
fiber
therebi
demolish
lung
tissu
structur
elastas
releas
lungdamag
mechan
discuss
massiv
pulmonari
neutrophil
infiltr
pediatr
patient
rsvinduc
bronchiol
might
thu
caus
irrepar
disrupt
lung
develop
predispos
infant
subsequ
asthma
incept
fig
addit
induc
airway
remodel
collater
tissu
damag
neutrophil
might
sensit
airway
asthma
mast
cell
recruit
detect
bronchoalveolar
lavag
fluid
patient
rsvinduc
bronchiol
airwayinfiltr
neutrophil
princip
produc
respons
pulmonari
express
longliv
mast
cell
migrat
accumul
lung
tissu
lungresid
mast
cell
specif
locat
bronchial
smooth
muscl
bundl
contribut
airway
hyperrespons
consid
crucial
pathogenesi
allerg
asthma
fig
dampen
excess
neutrophil
inflamm
rsvinduc
bronchiol
might
protect
lung
function
curtail
airway
sensit
reduc
risk
recurr
wheez
asthma
proofofconcept
random
doubleblind
placebocontrol
trial
macrolid
treatment
patient
rsvinduc
bronchiol
provid
tent
clinic
support
favor
dampen
neutrophil
inflamm
macrolid
antineutrophil
activ
vitro
attenu
neutrophil
airway
inflamm
patient
refractori
asthma
rsv
infect
mice
comparison
placebotr
patient
macrolidetr
patient
rsvinduc
bronchiol
show
reduc
nasal
lavag
level
experienc
fewer
day
bronchiol
respiratori
symptom
tend
toward
fewer
subsequ
wheez
episod
exhibit
delay
third
wheez
episod
rsv
immunoprophylaxi
costli
avail
highrisk
infant
reduc
rsvrelat
hospit
approxim
patient
support
care
sole
treatment
regimen
avail
clearli
new
treatment
option
sever
rsvinduc
bronchiol
requir
amelior
diseas
reduc
sequela
asthma
particular
promin
neutrophil
inflamm
patient
rsvinduc
bronchiol
repres
promis
target
examin
role
neutrophil
patient
rsv
infect
discuss
relev
thereof
therapi
asthma
prevent
studi
perform
rsv
regard
scarc
also
draw
inform
literatur
virus
particular
influenza
viru
infect
also
exhibit
sever
pulmonari
neutrophil
infiltr
neutrophil
injur
lung
multipl
way
releas
proteolyt
enzym
includ
elastas
microenviron
degranul
product
reactiv
oxygen
speci
ro
format
neutrophil
extracellular
trap
net
cell
death
program
known
netosi
stimul
mucu
product
fig
neutrophil
migrat
airway
influenza
infect
mice
depend
neutrophil
tertiari
granuleexpress
matrix
metalloproteinas
mmp
digest
extracellular
protect
lunginjuri
role
neutrophil
respiratori
tract
viral
infect
neutrophilinduc
mucu
product
limit
access
viral
particl
epithelium
obstruct
airflow
degranul
releas
antimicrobi
mediat
also
cytotox
host
cell
phagocytosi
opson
viral
particl
virusinfect
cell
limit
viral
spread
net
captur
deactiv
viral
particl
also
damag
healthi
bystand
cell
ecm
extracellular
matrix
prm
pattern
recognit
molecul
matrix
neutrophil
influx
airway
requir
control
influenza
viru
replic
mous
lung
howev
excess
proteolyt
activ
respons
high
viral
load
exacerb
patholog
pulmonari
inflamm
caus
noninfecti
agent
cigarett
smoke
implic
neutrophil
proteolyt
enzym
includ
cathepsin
g
neutrophil
elastas
proteinas
lung
tissu
destruct
well
inflammatori
milieu
lung
rsv
infect
induc
neutrophil
oxid
burst
abundantli
produc
ro
indiscrimin
oxid
biomolecul
compromis
function
therefor
ro
potent
antimicrobi
also
damag
host
cellular
structur
oxid
stress
rsv
infect
promot
lung
injuri
thu
neutrophilderiv
ro
like
contribut
lung
damag
patient
rsv
infect
net
dnabas
mesh
decor
histon
granular
antimicrobi
protein
peptid
includ
elastas
myeloperoxidas
mpo
adefensin
trap
microb
net
microbi
spread
minim
microb
kill
optim
high
local
concentr
antimicrobi
protein
peptid
exposur
neutrophil
rsv
particl
vitro
induc
net
format
specif
interact
rsv
fusion
f
protein
neutrophilexpress
tolllik
receptor
tlr
data
vivo
antivir
activ
net
conflict
genet
ablat
peptidylarginin
deiminas
requir
net
format
affect
viral
replic
mortal
mice
infect
influenza
viru
instead
net
locat
area
alveolar
damag
lung
influenza
virusinfect
mice
vitro
net
directli
damag
alveolar
epitheli
endotheli
cell
histon
compon
net
chiefli
respons
cytotox
effect
suggest
net
induc
lung
injuri
rather
suppress
viral
replic
howev
absenc
net
peptidylarginin
deiminas
mice
reduc
lung
patholog
influenza
infect
either
mous
model
human
influenza
viru
infect
net
appear
play
neither
benefici
patholog
role
contribut
net
viral
infect
might
viru
specif
depend
degre
net
induct
addit
directli
damag
respiratori
tract
neutrophil
contribut
airway
obstruct
induc
mucu
product
mucu
form
protect
barrier
viral
infect
limit
access
viral
particl
pulmonari
epithelium
howev
excess
mucu
product
might
caus
airway
obstruct
mous
neutrophil
promot
express
mucin
chief
compon
mucu
rsv
infect
thu
extens
neutrophil
infiltr
lung
might
contribut
airway
obstruct
result
wheez
observ
patient
sever
rsvinduc
bronchiol
pulmonari
enhanc
neutrophil
recruit
lung
earli
rsv
infect
induc
product
airway
epitheli
cell
amount
lung
pediatr
patient
rsvinduc
bronchiol
correl
degre
subsequ
pulmonari
neutrophil
influx
addit
induc
product
obstruct
mucu
airway
suggest
play
pathogen
role
lrti
rsv
associ
polymorph
gene
encod
sever
rsvinduc
bronchiol
support
notion
moreov
respons
h
cell
note
produc
enhanc
infant
rsvinduc
bronchiol
rsv
mous
model
also
link
h
respons
rsv
diseas
sever
pulmonari
neutrophil
recruit
lung
patholog
exacerb
rsvinfect
mice
increas
h
respons
caus
genet
ablat
receptor
moreov
genet
ablat
antibodymedi
block
rsvinfect
mice
reduc
neutrophil
inflamm
mucu
product
viral
load
improv
cytotox
tcell
respons
rsv
nonetheless
clear
whether
local
level
protect
harm
reduc
airway
reactiv
rsvinfect
mice
presensit
ovalbumin
mice
receiv
novel
attenu
bordetella
pertussi
vaccin
protect
rsv
infect
fashion
possibl
limit
respons
protect
wherea
excess
product
induc
immun
patholog
unrestrain
neutrophil
recruit
howev
earli
recruit
neutrophil
lung
patient
rsvinduc
bronchiol
unlik
mediat
adapt
h
respons
rsv
antigendriven
clonal
expans
differenti
h
cell
requir
sever
day
instead
might
role
natur
h
cell
acquir
effector
function
thymic
develop
regul
earlyphas
airway
neutrophil
respons
thu
natur
h
cell
might
promot
pathogen
neutrophildomin
respons
rsv
infect
neutrophil
antimicrobi
arsen
although
damag
lung
deploy
excess
also
shown
efficaci
virus
addit
tradit
bacteri
fungal
target
base
contribut
neutrophil
antivir
defens
suggest
inde
benefici
role
neutrophil
patient
viral
respiratori
tract
infect
report
influenza
viru
neutrophil
deplet
mice
neutrophilspecif
antibodi
treatment
result
enhanc
viral
replic
lung
damag
therefor
neutrophil
recruit
airway
rsv
infect
could
also
protect
respons
neutrophil
mediat
direct
antimicrobi
effect
essenc
known
effector
mechan
name
phagocytosi
degranul
net
format
fig
tabl
mean
phagocytosi
neutrophil
elimin
rsvinfect
cell
therebi
prevent
viral
replic
engulf
virion
limit
infect
new
cell
block
recognit
phagocytosi
apoptot
cell
local
annexin
v
administr
day
influenza
viru
inocul
increas
mortal
among
mice
mous
macrophag
neutrophil
phagocytos
influenza
virusinfect
apoptot
cell
vivo
process
amplifi
recogn
rsv
f
protein
express
surfac
virion
infect
cell
moreov
shown
vitro
herp
simplex
viru
antibodyand
complementmedi
opson
facilit
phagocytosi
viral
particl
virusinfect
cell
neutrophil
neutrophil
granul
contain
antimicrobi
protein
peptid
includ
adefensin
human
neutrophil
peptid
hnp
cathelicidin
ie
pentraxin
ptx
mpo
releas
microenviron
degranul
neutrophil
degranul
respons
vitro
stimul
rsv
particl
hnp
small
cation
amphipath
peptid
demonstr
antivir
activ
instanc
multipl
step
cellular
entri
inhibit
hnp
promot
influenza
viru
aggreg
uptak
neutrophil
whether
antivir
activ
hnp
extend
rsv
current
known
broad
antivir
activ
hpn
multipl
envelop
nonenvelop
virus
hint
possibl
recent
vitro
work
demonstr
cation
antimicrobi
peptid
possess
direct
antivir
activ
rsv
virion
protect
infect
epitheli
cell
rsvinduc
cell
death
inhibit
product
new
viral
particl
reduc
suscept
epitheli
cell
rsv
infect
low
serum
level
precursor
ie
associ
sever
infantil
rsvinduc
bronchiol
ptx
solubl
pattern
recognit
molecul
recogn
pathogenassoci
molecular
pattern
mediat
innat
humor
immun
function
resembl
antibodi
adapt
immun
system
activ
compliment
recruit
ie
classic
pathway
act
opsonin
interact
fcgriii
fcgrii
receptor
express
phagocyt
includ
neutrophil
matur
neutrophil
repres
major
reservoir
preform
readytous
well
pattern
recognit
molecul
direct
evid
antivir
activ
rsv
lack
demonstr
influenza
viru
mous
coronaviru
reduc
infect
virus
moreov
mice
inocul
either
viru
fare
wors
wildtyp
counterpart
rescu
administr
exogen
mpo
catalyz
product
hypochlor
acid
potent
antimicrobi
ro
abil
chlorin
oxid
great
varieti
biomolecul
secret
netbound
mpo
deactiv
particl
vitro
rsv
f
protein
induc
format
mpocoat
net
trigger
netosi
rosdepend
pathway
netbound
mpo
hnp
abolish
infect
particl
cocultur
neutrophil
reduc
infect
cell
netdepend
manner
thu
net
elicit
stimul
viru
possess
direct
antivir
activ
vitro
furthermor
releas
net
neutrophil
intraven
myxoma
poxviru
challeng
mice
protect
viral
infect
liver
cell
therefor
net
benefit
antivir
defens
vivo
discuss
netosi
defici
affect
cours
diseas
human
influenza
virusinocul
mice
contribut
protect
damag
net
antivir
defens
might
viru
organ
eg
liver
vs
lung
specif
recent
studi
demonstr
multipl
immun
regulatori
function
neutrophil
addit
role
effector
cell
patient
rsv
infect
describ
neutrophil
also
act
immun
regulatori
cell
fig
although
neutrophilmedi
immun
regul
context
rsv
infect
yet
examin
directli
gener
concept
deriv
studi
virus
guid
research
sever
understudi
role
neutrophil
patient
rsv
infect
focu
regulatori
role
potenti
involv
rsv
infect
complet
overview
reader
refer
number
recent
review
neutrophil
promot
antivir
tcell
respons
influenza
viru
antigendisplay
neutrophil
stimul
lunginfiltr
cell
produc
ifng
wherea
infect
epitheli
cell
elicit
cytolysi
stimul
ifng
product
neutrophil
enhanc
antivir
defens
rsv
infect
tcell
respons
influenza
airway
mice
maintain
infiltr
neutrophil
neutrophil
thu
regul
tcell
effector
function
site
viral
infect
neutrophil
effici
crosspres
phagocytos
antigen
naiv
cell
vivo
stimul
prolifer
ifng
product
cytolyt
activ
act
viral
antigen
shuttl
neutrophil
indirectli
induc
antivir
tcell
respons
mous
neutrophil
take
modifi
vaccinia
ankara
viru
skin
transport
viral
antigen
bone
marrow
local
phagocyt
antigenpres
cell
trigger
virusspecif
tcell
prolifer
establish
memori
moreov
neutrophil
indirectli
stimul
tcell
respons
recruit
immatur
dendrit
cell
dc
site
infect
secret
induc
dc
matur
direct
cellcel
contact
depend
alter
glycosyl
pattern
carcinoembryon
antigenrel
cell
adhes
molecul
specif
activ
neutrophil
homeostasi
innat
cytotox
lymphocyt
ie
natur
killer
nk
cell
neutrophil
depend
neutropen
patient
neutrophildeplet
mice
present
immatur
hyporespons
nk
cell
neutrophil
stimul
nk
cell
product
interact
adapt
humor
respons
stimul
neutrophil
well
cytokin
secret
ie
b
cellactiv
factor
tnf
famili
baff
prolifer
induc
ligand
april
splenic
neutrophil
induc
immunoglobulin
classswitch
recombin
somat
hypermut
antibodi
product
margin
zone
b
cell
neutrophil
also
suppress
adapt
immun
respons
system
inflamm
human
subject
induc
neutrophil
subset
cellsuppress
capabl
suppress
neutrophil
form
immunolog
synaps
cell
local
produc
burst
membraneassoci
hydrogen
peroxid
h
suppress
tcell
prolifer
furthermor
neutrophilderiv
thromboxan
limit
tcell
cytokin
product
respons
proteininadjuv
vaccin
mice
suppress
spread
tcell
respons
drain
lymph
node
inject
site
distal
lymph
node
neutrophil
indirectli
suppress
tcell
respons
deposit
mpo
lymph
node
impair
dc
function
passiv
manner
neutrophil
might
contribut
resolut
inflamm
depend
environment
stimuli
macrophag
acquir
proinflammatori
proresolut
phenotyp
phagocytosi
apoptot
neutrophil
macrophag
induc
regulatori
phenotyp
macrophag
might
contribut
resolut
inflamm
rsvinfect
cotton
rat
proresolut
macrophag
limit
lung
patholog
conceiv
neutrophil
abundantli
present
airway
sever
rsv
infect
without
play
major
role
either
pathogenesi
bronchiol
subsequ
incept
asthma
although
indic
neutrophil
inflamm
includ
airway
level
neutrophil
elastas
activ
correl
sever
bronchiol
cell
count
airwayinfiltr
neutrophil
invari
high
associ
rsv
diseas
sever
similar
rsvinduc
bronchiol
extens
neutrophil
infiltr
airway
alveoli
observ
bacteri
pneumonia
usual
absenc
wheez
neutrophil
contribut
incept
asthma
bronchiol
increas
risk
asthma
also
observ
bacteri
respiratori
tract
infect
earli
childhood
evid
support
limit
observ
highrisk
birth
cohort
futur
studi
attempt
valid
relationship
bacteri
respiratori
tract
infect
infanc
subsequ
develop
reactiv
airway
diseas
vast
number
lunginfiltr
neutrophil
patient
rsvinduc
bronchiol
appear
princip
instig
pulmonari
immunopatholog
secret
proteolyt
enzym
elastas
product
ro
net
releas
clearli
injur
lung
might
disrupt
delic
process
lung
develop
infanc
last
advers
consequ
lung
anatomi
function
suscept
chronic
diseas
includ
asthma
howev
direct
antivir
activ
neutrophil
mechan
well
regul
adapt
immun
respons
neutrophil
also
contribut
protect
antivir
respons
patient
sever
rsvinduc
bronchiol
balanc
neutrophil
antimicrobi
activ
collater
tissu
damag
appear
shift
toward
patholog
respons
henc
pharmacolog
suppress
neutrophil
activ
could
curtail
lung
injuri
possibl
approach
includ
neutrophilinhibitori
macrolid
inhibit
damag
neutrophilderiv
product
elastas
antagon
neutrophilmodulatori
adenosin
neutrophil
chemokin
receptor
blockad
target
neutrophilexpress
inhibitori
receptor
eagerli
await
result
futur
clinic
trial
treatment
rsv
infect
pharmacolog
agent
effect
dampen
neutrophil
inflamm
select
smallmolecul
receptor
antagonist
danirixin
clinicaltrialsgov
identifi
relationship
extens
neutrophil
infiltr
airway
earli
life
later
asthma
develop
might
limit
rsv
infect
lower
respiratori
tract
ill
infant
induc
virus
also
associ
subsequ
wheez
asthma
limit
evid
also
hint
causal
associ
bacteri
invas
respiratori
tract
subsequ
asthma
develop
colon
neonat
airway
pathogen
bacteria
induc
neutrophil
responseassoci
cytokin
associ
develop
persist
wheez
childhood
asthma
prospect
birth
cohort
moreov
among
prospect
follow
highrisk
children
respiratori
tract
infect
pathogen
bacteria
earli
life
associ
increas
risk
schoolag
asthma
fact
rather
specif
viral
bacteri
pathogen
total
number
earli
respiratori
tract
infect
correl
risk
childhood
asthma
studi
although
injuri
present
excess
neutrophil
essenti
antimicrobi
defens
safeti
treat
rsvinduc
bronchiol
neutrophil
suppress
could
improv
administr
rsv
antivir
prophylact
antibiot
recent
newli
develop
rsv
antivir
success
test
clinic
trial
wherein
healthi
adult
subject
challeng
rsv
howev
rsv
antivir
might
confer
limit
benefit
administ
sever
day
onset
symptom
influenza
oseltamivir
effect
administ
within
hour
symptom
onset
similarli
antivir
treatment
rsv
ideal
administ
close
initi
infect
possibl
effect
yet
rsv
load
alreadi
decreas
patient
admit
intens
care
unit
nonetheless
neutrophil
still
abundantli
present
lung
thu
neutrophilmedi
damag
airway
persist
fig
therefor
propos
suppress
neutrophil
activ
umbrella
rsvantivir
prophylact
antibiot
offer
promis
treatment
strategi
improv
outcom
infant
rsvinduc
bronchiol
reduc
risk
subsequ
asthma
